Discontinued — last reported Q4 '21

Stock Issuance Proceeds

Financing

Johnson & Johnson Stock Issuance Proceeds increased by 1090.7% to $1.27B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 200.5%, from $424.00M to $1.27B.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2021

How to read this metric

While it provides cash, frequent issuance can lead to share dilution unless offset by a robust share repurchase program.

Detailed definition

Cash received from the sale of common stock, which in large tech companies is primarily driven by employee participation...

Peer comparison

High-growth tech companies often have significant inflows here due to stock-based compensation structures.

Metric ID: cf_proceeds_from_stock_issuance

Historical Data

10 periods
 Q2 '21Q2 '22Q2 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$236.00M$321.00M-$11.00M$195.00M$95.00M$424.00M$124.00M$450.00M$107.00M$1.27B
QoQ Change+36.0%-103.4%>999%-51.3%+346.3%-70.8%+262.9%-76.2%>999%
YoY Change+36.0%-103.4%+963.6%+130.8%+12.6%+200.5%
Range-$11.00M$1.27B
CAGR+111.6%
Avg YoY Growth+206.7%
Median YoY Growth+83.4%

Stock Issuance Proceeds at Other Companies

Frequently Asked Questions

What is Johnson & Johnson's stock issuance proceeds?
Johnson & Johnson (JNJ) reported stock issuance proceeds of $1.27B in Q3 2025.
How has Johnson & Johnson's stock issuance proceeds changed year-over-year?
Johnson & Johnson's stock issuance proceeds increased by 200.5% year-over-year, from $424.00M to $1.27B.
What does stock issuance proceeds mean?
Cash the company received from selling its own shares, often to employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.